http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104450712-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115 |
| filingDate | 2014-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104450712-B |
| titleOfInvention | The sequence of oligonucleotides aglucon V4 2 of specific recognition Vasorin (VASN) albumen a kind of and application |
| abstract | The invention discloses a kind of oligonucleotides aglucon V4 2 for specific recognition Vasorin (VASN) albumen for belonging to molecular biosciences medicine technology field sequence and application.The present invention design specific sequences of V4 2, hold using 5 ' or 3 ' terminal modified, mark (such as FITC, biotin or digoxin) methods detect that V4 2 being capable of specific recognition Vasorin (VASN) albumen.V4 2 for the auxiliary diagnosis of liver cancer, targeted therapy or carries out related basic research of liver cancer diseases generations, development, process etc. as the part or Testing index of kit.The method of the present invention is simple, rapidly, sensitive, it is adaptable to the auxiliary diagnosis of clinical tumor serum specimen, knubble biological targeted therapy, with extensive clinical practice and base application prospect. |
| priorityDate | 2014-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.